WEBINAR: Leading experts to give their views on treating multiple myeloma patients during the COVID-19 pandemic

The COVID-19 pandemic continues to put a strain on healthcare delivery around the world. In this environment, haematologists are adapting their approach to treating multiple myeloma to minimise the risk to their patients.

Last Thursday, Professor Miles Prince hosted a webcast to explore the issues surrounding management of patients during this challenging time.

Joining him was leading haematologist, Dr Nada Hamad (St Vincent’s, Sydney). There was also a live cross to Professor Ola Landgren at the Memorial Sloane Kettering Centre, New York, who will provide an overview on approaches he and his colleagues are taking at the epicentre of the pandemic.